Ages2Come
Menu
View all results →
Categories
⚡ Breaking
Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says Tim Cook to be paid $47mn as Apple’s executive chair Are all TVs at risk from burn-in? Here's how to avoid the problem altogether At G20 Meeting, Scott Bessent Accuses China of Flooding the World With Cheap Exports Will self-flying planes transform the skies? Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says Tim Cook to be paid $47mn as Apple’s executive chair Are all TVs at risk from burn-in? Here's how to avoid the problem altogether At G20 Meeting, Scott Bessent Accuses China of Flooding the World With Cheap Exports Will self-flying planes transform the skies?
Business / Mobile

UniQure Shares Soar After FDA Reversal on Its Huntington’s Therapy

Source: bloombergMarkets June 17, 2026 · 04:27
UniQure NV shares soared after the company announced it will be able to seek US approval for its Huntington’s disease gene therapy before conducting a new study, a dramatic reversal that shows the Trump administration is relaxing its previous hard-line stance on drug reviews.
Read original article ← Back to Mobile

The original article opens on the publisher's website.

More from Mobile

View topic →